Prospera Financial Services Inc Mirati Therapeutics, Inc. Transaction History

Prospera Financial Services Inc

  • $3.5 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$39.16 - $88.71 $10,534 - $23,862
-269 Closed
0 $0
Q1 2022

May 04, 2022
BUY
$75.82 - $150.97 $20,395 - $40,610
269 New
269 $22,000
Q4 2020

Feb 12, 2021
SELL
$162.05 - $240.27 $108,897 - $161,461
-672 Closed
0 $0
Q3 2020

Nov 04, 2020
BUY
$113.26 - $167.27 $76,110 - $112,405
672 New
672 $112,000

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email